Company Overview - The company is a global leader in the injectable medicine space, showcasing a strong competitive advantage through its proprietary solutions and reputation for quality, reliability, and scale [3]. Business Model and Growth - The company has an attractive business model that supports long-term organic growth of 7% to 9% and margin expansion, primarily driven by a shift in product mix [4]. - The underlying drivers of growth are centered around high-value product components [4].